The Medical Research Network, LLC
New York, New York, United States
Pain control clinic in New York City, New York
134 E 93rd St, New York, NY 10128
About The Medical Research Network, LLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Medical Research Network, LLC
During the past decade, The Medical Research Network, LLC conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 30 clinical trials were completed, i.e. on
average, 103.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 23 clinical trials were completed. i.e. 287.5%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
2015-08-12
2025-12-31
Active, not recruiting
6,452
Cisplatin, Carboplatin and Etoposide or Temozolomide and Capecitabine in Treating Patients With Neuroendocrine Carcinoma of the Gastrointestinal Tract or Pancreas That Is Metastatic or Cannot Be Removed by Surgery
2015-11-06
2029-01-01
Recruiting
126
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
2017-01-13
2023-10-31
Active, not recruiting
818
Pegylated Liposomal Doxorubicin Hydrochloride With Atezolizumab and/or Bevacizumab in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2017-05-12
2023-06-30
Active, not recruiting
444
Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes
2017-09-29
2022-04-15
Terminated
23
Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
2017-12-22
2023-08-01
Active, not recruiting
1,670
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
2017-06-01
2024-08-01
Suspended
310
Assessing the Accuracy of Tumor Biopsies After Chemotherapy to Determine if Patients Can Avoid Breast Surgery
2017-04-13
2023-11-30
Suspended
175
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Medical Research Network, LLC" #1 sponsor was "Pfizer" with 11 trials, followed by "Naurex, Inc, an affiliate of Allergan plc" with 5 trials
sponsored, "Janssen Research & Development, LLC" with 4 trials sponsored, "Otsuka Pharmaceutical Development & Commercialization, Inc." with 4 trials sponsored and "The Medical Research Network"
with 4 trials sponsored. Other sponsors include 26 different institutions and
companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Medical Research Network, LLC"
#1 collaborator was "APCER Life Sciences" with 1 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Forest Laboratories" with 1 trials as a collaborator and "KCAS Bio" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at The Medical Research Network, LLC
According to Clinical.Site data, the most researched conditions in "The Medical Research Network, LLC" are
"Major Depressive Disorder" (7 trials), "Depressive Disorder, Major" (6 trials), "Low Back Pain" (4 trials), "Osteoarthritis" (4 trials) and "Social Anxiety Disorder" (4 trials). Many other conditions were trialed in "The Medical Research Network, LLC" in a lesser frequency.
Clinical Trials Intervention Types at The Medical Research Network, LLC
Most popular intervention types in "The Medical Research Network, LLC" are "Drug" (51 trials), "Biological" (8 trials) and "Other" (8 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (27 trials), "Rapastinel" (5 trials), "placebo" (3 trials), "tanezumab" (3 trials) and "CERC-301" (2 trials). Other intervention names were less common.
Clinical Trials Genders at The Medical Research Network, LLC
The vast majority of trials in "The Medical Research Network, LLC" are
59 trials for "All" genders.
Clinical Trials Status at The Medical Research Network, LLC
Currently, there are NaN active trials in "The Medical Research Network, LLC".
1 are not yet recruiting,
4 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 42 completed trials in The Medical Research Network, LLC,
undefined suspended trials,
and 9 terminated clinical trials to date.
Out of the total trials that were conducted in The Medical Research Network, LLC, 0 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 36 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 3 trials that are defined as “Not Applicable".